SPLV vs XBI
Invesco S&P 500 Low Volatility ETF vs SPDR S&P Biotech ETF
- • SPLV has the lower expense ratio at 0.25% vs 0.35% for XBI.
- • SPLV pays a higher dividend yield (2.11%).
Side-by-side metrics
| Metric | SPLV | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.25% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.11% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $7.23B | $8.30B |
YTD return | 3.44% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.45 | 1.09 |
P/E ratio | 22.04 | — |
Last price | $73.12 | $133.66 |
Inception | — | — |
Issuer | Invesco | State Street |
SPLV top holdings
| CNP | CenterPoint Energy Inc | 1.35% |
| WEC | WEC Energy Group Inc | 1.35% |
| PNW | Pinnacle West Capital Corp | 1.35% |
| SO | Southern Co | 1.34% |
| ATO | Atmos Energy Corp | 1.34% |
| AEE | Ameren Corp | 1.34% |
| DTE | DTE Energy Co | 1.33% |
| EVRG | Evergy Inc | 1.31% |
| LNT | Alliant Energy Corp | 1.31% |
| DUK | Duke Energy Corp | 1.30% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About SPLV
SPLV (Invesco S&P 500 Low Volatility ETF) is 100 lowest-volatility S&P 500 stocks. Managed by Invesco, the fund carries $7.2B in assets under management, an expense ratio of 0.25%, a dividend yield of 2.11%. Its largest holding is CenterPoint Energy Inc (CNP), which represents 1.4% of the portfolio. Real Estate is the fund's largest sector exposure at 14.8%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.